Home › Metastatic Cancer › Illinois › Arlington Heights
Metastatic Cancer clinical trials in Arlington Heights, IL
6 studies for Metastatic Cancer are looking for participants at sites in and around Arlington Heights (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Advocate Good Shepherd Hospital, Barrington · 9 mi away
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 3
- Illinois Cancer Specialists, Arlington Heights
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Illinois Cancer Specialists, Arlington Heights
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RecruitingObservational study
- Northwest Oncology & Hematology, Elk Grove Village · 6 mi away
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Illinois Cancer Specialists, Arlington Heights
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- Northwest Oncology & Hematology, Barrington · 9 mi away
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Arlington Heights
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer12 studies
- Lung Cancer9 studies
- Heart Failure7 studies
- Breast Cancer7 studies
- Ulcerative Colitis6 studies
- Colon Cancer6 studies
- Ovarian Cancer5 studies
- Obesity4 studies
- Overweight4 studies
- Cancer (all types)3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.